ATE279187T1 - Pharmazeutische zusammensetzung die ein polymer assoziert oder konjugiert an einem salz einer phenylalkylcarboxylsäure enthält; die konjugierte polymere und ihre anwendungen - Google Patents

Pharmazeutische zusammensetzung die ein polymer assoziert oder konjugiert an einem salz einer phenylalkylcarboxylsäure enthält; die konjugierte polymere und ihre anwendungen

Info

Publication number
ATE279187T1
ATE279187T1 AT01940634T AT01940634T ATE279187T1 AT E279187 T1 ATE279187 T1 AT E279187T1 AT 01940634 T AT01940634 T AT 01940634T AT 01940634 T AT01940634 T AT 01940634T AT E279187 T1 ATE279187 T1 AT E279187T1
Authority
AT
Austria
Prior art keywords
conjugated
pharmaceutical composition
composition containing
salt
applications
Prior art date
Application number
AT01940634T
Other languages
English (en)
Inventor
Thierry Avramoglou
Rozita Bagheri
Frederic Chaubet
Michel Crepin
Latifa Dahri-Correia
Melanie Dibenedetto
Claudia Gervelas
Remi Huynh
Jacqueline Jozefonvicz
Original Assignee
Biodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biodex filed Critical Biodex
Application granted granted Critical
Publication of ATE279187T1 publication Critical patent/ATE279187T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT01940634T 2000-06-02 2001-05-30 Pharmazeutische zusammensetzung die ein polymer assoziert oder konjugiert an einem salz einer phenylalkylcarboxylsäure enthält; die konjugierte polymere und ihre anwendungen ATE279187T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0007117A FR2809735B1 (fr) 2000-06-02 2000-06-02 Composition pharmaceutique contenant au moins un polymere associe ou conjugue a au moins un sel d'un acide phenylalkycarboxylique, polymeres conjugues et leurs applications
PCT/FR2001/001672 WO2001091742A1 (fr) 2000-06-02 2001-05-30 Composition pharmaceutique contenant au moins un polymere associe ou conjugue a au moins un sel d'un acide phenylalkylcarboxylique, polymeres conjugues et leurs applications

Publications (1)

Publication Number Publication Date
ATE279187T1 true ATE279187T1 (de) 2004-10-15

Family

ID=8850928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01940634T ATE279187T1 (de) 2000-06-02 2001-05-30 Pharmazeutische zusammensetzung die ein polymer assoziert oder konjugiert an einem salz einer phenylalkylcarboxylsäure enthält; die konjugierte polymere und ihre anwendungen

Country Status (8)

Country Link
US (1) US20030171333A1 (de)
EP (1) EP1289515B1 (de)
JP (1) JP2003534374A (de)
AT (1) ATE279187T1 (de)
CA (1) CA2410882A1 (de)
DE (1) DE60106436D1 (de)
FR (1) FR2809735B1 (de)
WO (1) WO2001091742A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080161230A1 (en) * 2004-04-23 2008-07-03 Novexin Limited Methods and Kits for Stabilising, Protecting and Solubilising Proteins
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
FR2966248B1 (fr) 2010-10-18 2020-05-01 Centre National De La Recherche Scientifique (Cnrs) Procede de fonctionnalisation de surfaces pour la detection d'analytes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3793065A (en) * 1972-03-10 1974-02-19 Owens Corning Fiberglass Corp Size coated glass fibers
DK110188D0 (da) * 1988-03-02 1988-03-02 Claus Selch Larsen High molecular weight prodrug derivatives of antiinflammatory drugs
FR2657782B1 (fr) * 1990-02-06 1992-05-22 Therapeutiques Substitutives Nouvel agent antitumoral derive du dextrane.
AU650914B2 (en) * 1990-11-06 1994-07-07 Fgn, Inc. Esters and amides of substituted phenyl acetic acids
CA2091410A1 (en) * 1993-03-10 1994-09-11 Thomas C. Usher Pharmaceutical preparations for the treatment of various viral diseases and cancers
WO1995000177A1 (en) * 1993-06-17 1995-01-05 Dextran Products Limited Pharmaceutical preparation and a method for inhibiting the replication of various viruses

Also Published As

Publication number Publication date
FR2809735A1 (fr) 2001-12-07
EP1289515A1 (de) 2003-03-12
EP1289515B1 (de) 2004-10-13
CA2410882A1 (en) 2001-12-06
DE60106436D1 (de) 2004-11-18
US20030171333A1 (en) 2003-09-11
WO2001091742A1 (fr) 2001-12-06
JP2003534374A (ja) 2003-11-18
FR2809735B1 (fr) 2003-08-01

Similar Documents

Publication Publication Date Title
DE69017167D1 (de) Organisches polymer, dessen herstellung und härtbare zusammensetzung, die es enthält.
DK1163274T3 (da) Fremgangsmåde til tværbinding af hyaluronsyre til polymerer
EP1595884A3 (de) Salz einer Sulfonsäure mit Clopidogrel und dessen Verwendung zur Herstellung pharmazeutischer Formulierungen
ATE290882T1 (de) Pharmazeutische mischung gegen krebs, die ein 4- chinazolinamin in kombination mit paclitaxel, carboplatin or vinorelbine enthält
SV1999000048A (es) Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv
ATE551046T1 (de) Polymere duftkapseln und ihre herstellung
ID29534A (id) Turunan-turunan asam pirazolkarboksilat, pembuatannya, komposisi-komposisi farmasi yang mengandungnya
ATE477301T1 (de) Bei niedrigen temperaturen flüssige polymere polythioether
CY1105020T1 (el) Υποκαταστατες διαζεπανες
BRPI0416114A (pt) materiais compósitos compreendendo nanopartìculas carregadas com metal
DE60118790D1 (de) Polymere biomaterialien, die silsesquioxan-monomere enthalten
BRPI0408347A (pt) derivados de pirimidina
CA2399039A1 (en) Hyaluronic acid gel, method of its production and medical material containing it
ATE425767T1 (de) Konjugate von cyanovirin-varianten und einem polyalkylenoxid
ATE435506T1 (de) Konjugierte polymere, deren darstellung und verwendung
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
ATE518543T1 (de) Topisches hautmittel mit modifiziertem ton zur verhinderung von entzündungen
ATE401875T1 (de) Pharmazeutische feste dispersionen von modafinil- verbindungen
BR0311700A (pt) Processo para a produção de uma preparação em forma de pelìcula e preparação em forma de pelìcula
DE59909764D1 (de) Mucoadhäsive polymere, deren verwendung sowie deren herstellungsverfahren
ATE496109T1 (de) Umsetzungsprodukte von mercaptobenzothiazolen, mercaptothiazolinen und mercaptobenzimidazolen mit epoxiden als schmiermitteladditive
PT1210384E (pt) Composicoes de revestimento inorganicas, um processo para a sua preparacao bem como a sua utilizacao
TW200510510A (en) Polyquinoline copolymer and organic electroluminescence element using the same
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
ATE279187T1 (de) Pharmazeutische zusammensetzung die ein polymer assoziert oder konjugiert an einem salz einer phenylalkylcarboxylsäure enthält; die konjugierte polymere und ihre anwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties